Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases.

Chronic rheumatic diseases may impose greater long-term financial burdens than cancer, particularly for younger adults, ...

Rheumatic heart disease (RHD) may sound rare, but it is one of the most common causes of heart problems in young people across Africa. It remains a largely preventable but devastating condition that ...

GLP-1RA use was associated with a lower incidence of rheumatic diseases such as rheumatoid arthritis, gout, and ...

Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced incidence of ...

Learn about rheumatic fever—its causes, symptoms, diagnosis, treatment, and prevention—to protect heart health and ensure ...

According to a recent study, 44% of people with chronic conditions who responded to a population-based survey experienced medication-related burden (MRB). The burden was most common among people with ...